Christopher Pirie
About Christopher Pirie
Christopher Pirie is the Co-Founder and COO of Manus Bio and Virvio, with a PhD in Biological Engineering from MIT. He has extensive experience in protein engineering, enzyme engineering, and biopharmaceutical business development.
Christopher Pirie's Educational Background
Christopher Pirie earned a PhD in Biological Engineering from the Massachusetts Institute of Technology (MIT). His academic focus included protein engineering, with a specific interest in oncology biotherapeutics. This rigorous educational foundation has been instrumental in his subsequent professional endeavors in the fields of synthetic biology and biopharmaceuticals.
Co-Founder and COO of Manus Bio
In 2011, Christopher Pirie co-founded Manus Bio, a synthetic biology company dedicated to developing sustainable chemical manufacturing methods. As Chief Operating Officer, he built and ran the enzyme engineering team, playing a crucial role in the company's research and development efforts. Additionally, he led the intellectual property development initiatives at Manus Bio, securing patents and protecting the company's innovations.
Co-Founder of Virvio
In 2016, Christopher Pirie co-founded Virvio, a biopharmaceutical company focused on creating designer mini-proteins for treating respiratory diseases such as influenza. Within Virvio, he has led efforts related to grants administration, business development, and financing, helping the company secure essential resources and expand its operations in the biopharmaceutical industry.
Global Entrepreneurship Coaching with MIT Sloan
Beyond his roles at Manus Bio and Virvio, Christopher Pirie coaches global entrepreneurship bootcamps around the world in collaboration with the MIT Sloan Business School. His involvement in these bootcamps allows him to share his knowledge and expertise with aspiring entrepreneurs, contributing to the growth of innovative startups on a global scale.